Improving Attention Deficit Hyperactivity Disorder Treatment Adherence and Outcome in Primary Care Settings

Ann & Robert H Lurie Children's Hospital of Chicago

Status: Completed

Conditions: Attention Deficit Disorder With Hyperactivity

Treatments: Behavioral: Physician training

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00179894

DSIR 82-SECH

R01MH066866 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This study will determine the effectiveness of educating pediatricians about attention deficit hyperactivity disorder treatment guidelines in improving child behavior and pediatricians' adherence to medication guidelines.

Full description

The most effective treatment for improving the core symptoms of inattention, impulsivity and hyperactivity in children with attention deficit hyperactivity disorder (ADHD) involves the use of stimulant medications. Most children with ADHD are treated by pediatricians, but the treatment provided is often less than optimal. This study is designed to see if training for pediatricians in following guidelines for management of first-line medicines for ADHD leads to improvement in child behavior, and whether the physicians can adhere to the guidelines.

Over 100 studies have shown that stimulant medications are effective for improving the core symptoms of Attention Deficit Hyperactivity Disorder (ADHD). Approximately 70% of children who receive ADHD medications are treated by their primary care pediatrician, but studies show that management is not always optimal. The present study is designed to see if child behavior can be improved by training pediatricians in the use of guidelines for treating ADHD, and whether the physicians can adhere to the guidelines. Twenty-four pediatric practices were randomized to a treatment as usual or specialized care (receiving training in guidelines and computer assisted monitoring of patient progress and medication titration). Children are assessed with parent and teacher reports at baseline, 4-, 9-, and 12-months post initiation of treatment, and classroom observations of behavior are assessed at baseline, 6-, and 12-months. Approximately 400 children are to be enrolled.

Enrollment: 270 patients

Sex: All

Ages: 6 to 11 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Presence of ADHD
• Not currently on medication

Exclusion criteria

• No serious neurological disorders of sever mental health problems (suicidal behavior, autism)

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Factorial Assignment

Masking: None (Open label)

---

270 participants in 2 patient groups

1 Physician training

Experimental group

Description:

Physician participants will receive training in guidelines and medication monitoring

Treatment:

Behavioral: Physician training

2

No Intervention group

Description:

Physician participants will provide usual care and no special intervention